Ángel Cid-Arregui

1.5k total citations
44 papers, 1.1k citations indexed

About

Ángel Cid-Arregui is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Ángel Cid-Arregui has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Epidemiology and 13 papers in Genetics. Recurrent topics in Ángel Cid-Arregui's work include Virus-based gene therapy research (12 papers), Immunotherapy and Immune Responses (10 papers) and Cervical Cancer and HPV Research (9 papers). Ángel Cid-Arregui is often cited by papers focused on Virus-based gene therapy research (12 papers), Immunotherapy and Immune Responses (10 papers) and Cervical Cancer and HPV Research (9 papers). Ángel Cid-Arregui collaborates with scholars based in Germany, Iran and Mexico. Ángel Cid-Arregui's co-authors include Mansour Poorebrahim, Harald zur Hausen, Elham Fakhr, Alejandro Garcı́a-Carrancá, Prasert Auewarakul, Lutz Gissmann, Stina L. Wickström, Rolf Kiessling, Jeroen Melief and Yago Pico de Coaña and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Ángel Cid-Arregui

43 papers receiving 1.1k citations

Peers

Ángel Cid-Arregui
Florentina Marches United States
Kathleen A. McGuire United States
Hiroko Yaguchi Japan
Peter Gee Japan
Gloria H. Y. Lin United States
Jeff D. Colbert United States
Alanna Ruddell United States
Wolfgang Bohn Germany
Z. Sean Juo United States
Patricia Barral United Kingdom
Florentina Marches United States
Ángel Cid-Arregui
Citations per year, relative to Ángel Cid-Arregui Ángel Cid-Arregui (= 1×) peers Florentina Marches

Countries citing papers authored by Ángel Cid-Arregui

Since Specialization
Citations

This map shows the geographic impact of Ángel Cid-Arregui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángel Cid-Arregui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángel Cid-Arregui more than expected).

Fields of papers citing papers by Ángel Cid-Arregui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángel Cid-Arregui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángel Cid-Arregui. The network helps show where Ángel Cid-Arregui may publish in the future.

Co-authorship network of co-authors of Ángel Cid-Arregui

This figure shows the co-authorship network connecting the top 25 collaborators of Ángel Cid-Arregui. A scholar is included among the top collaborators of Ángel Cid-Arregui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángel Cid-Arregui. Ángel Cid-Arregui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cid-Arregui, Ángel, et al.. (2023). Association of Prevotella intermedia with oropharyngeal cancer: A patient-control study. Heliyon. 9(3). e14293–e14293. 14 indexed citations
3.
4.
Poorebrahim, Mansour, et al.. (2021). Correction: TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential. Cancer Gene Therapy. 28(6). 738–738. 1 indexed citations
5.
Poorebrahim, Mansour, et al.. (2021). TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential. Cancer Gene Therapy. 28(6). 581–589. 40 indexed citations
6.
Jarahian, Mostafa, Nadine El Banna, Kayhan Azadmanesh, et al.. (2021). Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs Recognize Ebolavirus Glycoprotein. Journal of Innate Immunity. 14(2). 135–147. 4 indexed citations
7.
Poorebrahim, Mansour, Mohammad Foad Abazari, Solmaz Sadeghi, et al.. (2020). Genetically modified immune cells targeting tumor antigens. Pharmacology & Therapeutics. 214. 107603–107603. 20 indexed citations
8.
Poorebrahim, Mansour, Jeroen Melief, Yago Pico de Coaña, et al.. (2020). Counteracting CAR T cell dysfunction. Oncogene. 40(2). 421–435. 108 indexed citations
9.
Quandt, Jasmin, Michael Bartoschek, Rainer Will, et al.. (2018). Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses. OncoImmunology. 7(12). e1500671–e1500671. 35 indexed citations
10.
Cid-Arregui, Ángel. (2015). Perspectives in the treatment of pancreatic adenocarcinoma. World Journal of Gastroenterology. 21(31). 9297–9297. 110 indexed citations
11.
García‐Chagollán, Mariel, Luis Felipe Jave‐Suárez, Jesse Haramati, et al.. (2013). Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1. Journal of Biomedical Science. 20(1). 60–60. 13 indexed citations
12.
Toro‐Arreola, Susana del, Adriana Aguilar‐Lemarroy, Ángel Cid-Arregui, et al.. (2011). MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines. Cancer Cell International. 11(1). 15–15. 17 indexed citations
13.
Cid-Arregui, Ángel. (2009). Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer. PubMed. 3(1). 67–83. 20 indexed citations
14.
Daneri‐Navarro, Adrián, Alicia Del Toro‐Arreola, Ángel Cid-Arregui, et al.. (2008). Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer. 8(1). 16–16. 72 indexed citations
15.
Darnell, Grant A., Wayne A. Schroder, Toni Antalis, et al.. (2007). Human Papillomavirus E7 Requires the Protease Calpain to Degrade the Retinoblastoma Protein. Journal of Biological Chemistry. 282(52). 37492–37500. 31 indexed citations
16.
García‐Villa, Enrique, Rocío Tapia, Ángel Cid-Arregui, et al.. (2006). Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding. BMC Cancer. 6(1). 218–218. 9 indexed citations
17.
18.
Cid-Arregui, Ángel & Alejandro Garcı́a-Carrancá. (1997). Microinjection and transgenesis: strategies and protocols.. Springer eBooks. 22 indexed citations
19.
Cid-Arregui, Ángel, et al.. (1995). Mechanisms of neuronal polarity. Neurobiology of Aging. 16(3). 239–243. 15 indexed citations
20.
Simons, Mikael, et al.. (1995). Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites. Journal of Neuroscience Research. 41(1). 121–128. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florentina Marches Breakdown of academic impact, for papers by Kathleen A. McGuire Breakdown of academic impact, for papers by Hiroko Yaguchi Breakdown of academic impact, for papers by Peter Gee Breakdown of academic impact, for papers by Gloria H. Y. Lin Breakdown of academic impact, for papers by Jeff D. Colbert Breakdown of academic impact, for papers by Alanna Ruddell Breakdown of academic impact, for papers by Wolfgang Bohn Breakdown of academic impact, for papers by Z. Sean Juo Breakdown of academic impact, for papers by Patricia Barral
Rankless by CCL
2026